Skip to content

Analysis of the Variation in Caspase-8 Availability and Cleavage in Oral Squamous Cell Carcinoma

Analysis of the Variation in Caspase-8 Availability and Cleavage in Oral Squamous Cell Carcinoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03877159
Enrollment
100
Registered
2019-03-15
Start date
2017-11-11
Completion date
2021-01-30
Last updated
2020-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Cancer

Brief summary

Control of cell death is frequently disrupted in cancer resulting in overgrowth of tumour cells. Caspase-8 is a key enzyme involved in controlling cell death. This study examines the importance of caspase-8 in oral cancer.

Detailed description

Control of cell death is frequently disrupted in cancer resulting in overgrowth of tumour cells. The caspase family of enzymes are the key performers of controlled cell death and caspase-8 is frequently mutated in oral cancer. This study will perform DNA sequencing to determine if the gene is wild-type (not mutated). The abundance of inactive (uncleaved) and active (cleaved) caspase-8 will be determined. The levels of the proteins that caspase-8 interacts with (including caspase-3) will be determined. Results will be correlated with tumour stage, patient outcome and the presence of immune cells and other microscopic features. This will improve the understanding of the importance of caspase-8 in oral cancer.

Interventions

There is no intervention. This is a retrospective study analysing archived tumour samples.

Sponsors

Guy's and St Thomas' NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Oral cancer * Sufficient follow up data

Exclusion criteria

* Patient has indicated that they do not wish their tissue to be used for research. * . The quantity or quality of tissue is too little or poor to provide adequate material without significant reserve. * The material contains bone.

Design outcomes

Primary

MeasureTime frameDescription
Caspase-8 activity in oral cancer and its impact on disease progressionUp to 3 yearsMolecular analysis of caspase-8 activity will be undertaken and correlated with tumour features and outcome.

Countries

United Kingdom

Contacts

Primary ContactRobert Kennedy, BSc PhD BDS
robert.kennedy@kcl.ac.uk07815501088

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026